Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Amgen
Children's Oncology Group
Takeda
Northwestern University
AbbVie
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Amgen Research (Munich) GmbH
Baylor College of Medicine
LEO Pharma
Mayo Clinic
University of North Carolina, Chapel Hill
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Wake Forest University Health Sciences
Vanderbilt University Medical Center
Amgen Research (Munich) GmbH
Mayo Clinic
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Radiation Therapy Oncology Group
Alliance for Clinical Trials in Oncology
FDA Office of Orphan Products Development
Seagen Inc.
Asan Medical Center
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of California, San Francisco